Extravasation of docetaxel: A red hand syndrome

Archives of Dermatology

Volumn 141, Issue 10, 2005, Pages 1326-1327

  Barceló, Ramón ^a   Viteri, Ainhoa ^b   Muñoz, Alberto ^b   Carrera, Sergio ^b   Rubio, Itziar ^b   López Vivanco, Guillermo ^b  

^a HOSPITAL DE CRUCES   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DOCETAXEL; IBUPROFEN; STEROID;

ADULT; ANAMNESIS; CASE REPORT; DIABETES MELLITUS; EPIDERMOLYSIS; EXTRAVASATION; HUMAN; LIVER CIRRHOSIS; LUNG NON SMALL CELL CANCER; MALE; NOTE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; TAXOIDS;

EID: 27144445048     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.141.10.1326     Document Type: Note

References (5)

1. Aventis Pharmaceuticals Inc. Prescribing information: Taxotere (docetaxel) injection concentrate. Available at: http://www.taxotere.com/ professional/home.do. Accessed March 5, 2005.
2. Berghammer P, Pohnl R, Baur M, Dittrich C. Docetaxel extravasation. Support Care Cancer. 2001;9:131-134.
3. Ho C-H, Yang C-H, Chu C-Y. Vesicant-type reaction due to docetaxel extravasation. Acta Derm Venereol. 2003;83:467-468.
4. El Saghir NS, Otrock ZK. Docetaxel extravasation into normal breast during breast cancer treatment. Anticancer Drugs. 2004;15:401-404.
5. Ener RA, Meglathery SB, Styler M. Extravasation of systemic hematooncological therapies. Ann Oncol. 2004;15:858-862.